Fewer shots for kidney patients? study tests monthly anemia treatment
NCT ID NCT07025460
Summary
This study tested if giving a drug for anemia (darbepoetin alfa) just once a month works as well as giving it every two weeks for people with advanced kidney disease who are not on dialysis. The goal was to see if the less frequent schedule could maintain healthy red blood cell levels while making treatment easier for patients. All 40 participants completed the study, and the monthly schedule was found to be just as effective as the biweekly one.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institutional Review Board, Gangnam Severance Hospitial Yonsei University College of Medicine
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.